10 results on '"Krane, M"'
Search Results
2. Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene.
- Author
-
Lahm H, Stieglbauer S, Neb I, Doppler S, Schneider S, Dzilic E, Lange R, Krane M, and Dreßen M
- Subjects
- Humans, CRISPR-Cas Systems, T-Box Domain Proteins genetics, T-Box Domain Proteins metabolism, Mutation genetics, Transcription Factors genetics, Transcription Factors metabolism, Phenotype, Exons genetics, Induced Pluripotent Stem Cells metabolism
- Abstract
TBX5 is a transcription factor (TF) playing essential role during cardiogenesis. It is well known that TF mutations possibly result in non- or additional binding of the DNA due to conformational changes of the protein. We introduced a Holt-Oram Syndrome (HOS) patient-specific TBX5 mutation c.920_C > A heterozygously in a healthy induced pluripotent stell cell (iPSC) line. This TBX5 mutation results in conformational changes of the protein and displayed ventricular septal defects in the patient itself. Additionally we introduced a FLAG-tag on the TBX5 mutation-carrying allele. The resulting heterozygous TBX5-FLAG iPSC lines are a powerful tool to investigate altered TF activity bonding., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Markus Krane reports a relationship with German Research Foundation that includes: funding grants. Markus Krane reports a relationship with Deutsches Zentrum für Herz-Kreislauf-Forschung that includes: funding grants., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
3. Generation of two CRISPR/Cas edited human induced pluripotent stem cell lines (DHMi005-A-3 and DHMi005-A-4) carrying a FLAG-tag after exon 9 of the TBX5 gene.
- Author
-
Lahm H, Stieglbauer S, Neb I, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M, and Dreßen M
- Subjects
- Humans, Exons genetics, CRISPR-Cas Systems genetics, Induced Pluripotent Stem Cells metabolism
- Abstract
Although TBX5 plays a major role during human cardiogenesis and initiates and controls limb development, many of its interactions with genomic DNA and the resulting biological consequences are not well known. Existing anti-TBX5-antibodies work very inefficiently in certain applications such as ChIP-Seq analysis. To circumvent this drawback, we introduced a FLAG-tag sequence into the TBX5 locus at the end of exon 9 prior to the stop codon by CRISPR/Cas9. The expressed TBX5-FLAG fusion protein can effectively be precipitated by anti-FLAG antibodies. Therefore, these gene-edited iPSC lines represent powerful cellular in vitro tools to unravel TBX5:DNA interactions in detail., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene.
- Author
-
Lahm H, Heinrich P, Zierler E, Dzilic E, Neb I, Luzius T, Doppler SA, Schneider S, Lange R, Krane M, and Dreßen M
- Subjects
- CRISPR-Cas Systems genetics, Humans, Mutation genetics, Point Mutation, T-Box Domain Proteins metabolism, Induced Pluripotent Stem Cells metabolism, T-Box Domain Proteins genetics, Upper Extremity Deformities, Congenital genetics
- Abstract
A number of mutations in the human TBX5 gene have been described which cause Holt-Oram syndrome, a severe congenital disease associated with abnormalities in heart and upper limb development. We have used a prime-editing approach to introduce a patient-specific disease-causing TBX5 mutation (c.920_C > A) into an induced pluripotent stem cell (iPSC) line from a healthy donor. The resulting iPSC line provides a powerful tool to identify and analyze the biological and molecular impact of this specific TBX5 mutation in comparison to the isogenic control iPSC line during cardiac development., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
5. Establishment of a patient-specific induced pluripotent stem cell line DHMi004-A from a male Holt-Oram syndrome patient with verified TBX5 mutation.
- Author
-
Dreßen M, Lahm H, Neb I, Luzius T, Doppler SA, Schneider S, Dzilic E, Lange R, and Krane M
- Subjects
- Abnormalities, Multiple, Amino Acids genetics, Heart Defects, Congenital, Heart Septal Defects, Atrial, Humans, Lower Extremity Deformities, Congenital, Male, Mutation genetics, Upper Extremity Deformities, Congenital, Induced Pluripotent Stem Cells, T-Box Domain Proteins genetics
- Abstract
The Holt-Oram syndrome (HOS) is a rare autosomal dominant disorder, mostly based on mutations in the TBX5 gene. Patients show malformation of at least one upper limb along with congenital heart defects. The established induced pluripotent stem cell (iPSC) line was generated from a patient displaying pronounced and typical features of HOS and carrying a single-nucleotide change c.920_C>A leading to an amino acid change from proline to threonine at amino acid position 85, which appeared de novo. Adipose fibroblasts from the patient were reprogrammed using Sendai virus. Pluripotency of the iPSCs was fully demonstrated., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Levitating Cells to Sort the Fit and the Fat.
- Author
-
Puluca N, Durmus NG, Lee S, Belbachir N, Galdos FX, Ogut MG, Gupta R, Hirano KI, Krane M, Lange R, Wu JC, Wu SM, and Demirci U
- Subjects
- Cell Line, Humans, Induced Pluripotent Stem Cells pathology, Lipid Metabolism, Inborn Errors genetics, Lipid Metabolism, Inborn Errors pathology, Myocytes, Cardiac pathology, Induced Pluripotent Stem Cells metabolism, Lipase deficiency, Lipid Metabolism, Inborn Errors metabolism, Myocytes, Cardiac metabolism
- Abstract
Density is a core material property and varies between different cell types, mainly based on differences in their lipid content. Sorting based on density enables various biomedical applications such as multi-omics in precision medicine and regenerative repair in medicine. However, a significant challenge is sorting cells of the same type based on density differences. Here, a new method for real-time monitoring and sorting of single cells based on their inherent levitation profiles driven by their lipid content is reported. As a model system, human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) from a patient with neutral lipid storage disease (NLSD) due to loss of function of adipose triglyceride lipase (ATGL) resulting in abnormal lipid storage in cardiac muscle are used. This levitation-based strategy detects subpopulations within ATGL-deficient hiPSC-CMs with heterogenous lipid content, equilibrating at different levitation heights due to small density differences. In addition, sorting of these differentially levitating subpopulations are monitored in real time. Using this approach, sorted healthy and diseased hiPSC-CMs maintain viability and function. Pixel-tracking technologies show differences in contraction between NLSD and healthy hiPSC-CMs. Overall, this is a unique approach to separate diseased cell populations based on their intracellular lipid content that cannot be achieved using traditional flow cytometry techniques., (© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2020
- Full Text
- View/download PDF
7. Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species.
- Author
-
Lahm H, Doppler S, Dreßen M, Werner A, Adamczyk K, Schrambke D, Brade T, Laugwitz KL, Deutsch MA, Schiemann M, Lange R, Moretti A, and Krane M
- Subjects
- Animals, Embryonic Stem Cells cytology, Humans, Induced Pluripotent Stem Cells cytology, Mice, Mice, Transgenic, Swine, Carbocyanines pharmacology, Cellular Reprogramming, Embryonic Stem Cells metabolism, Gene Expression Regulation, Induced Pluripotent Stem Cells metabolism, Oligonucleotides pharmacology
- Abstract
The generation of induced pluripotent stem (iPS) cells has successfully been achieved in many species. However, the identification of truly reprogrammed iPS cells still remains laborious and the detection of pluripotency markers requires fixation of cells in most cases. Here, we report an approach with nanoparticles carrying Cy3-labeled sense oligonucleotide reporter strands coupled to gold-particles. These molecules are directly added to cultured cells without any manipulation and gene expression is evaluated microscopically after overnight incubation. To simultaneously detect gene expression in different species, probe sequences were chosen according to interspecies homology. With a common target-specific probe we could successfully demonstrate expression of the GAPDH house-keeping gene in somatic cells and expression of the pluripotency markers NANOG and GDF3 in embryonic stem cells and iPS cells of murine, human, and porcine origin. The population of target gene positive cells could be purified by fluorescence-activated cell sorting. After lentiviral transduction of murine tail-tip fibroblasts Nanog-specific probes identified truly reprogrammed murine iPS cells in situ during development based on their Cy3-fluorescence. The intensity of Nanog-specific fluorescence correlated positively with an increased capacity of individual clones to differentiate into cells of all three germ layers. Our approach offers a universal tool to detect intracellular gene expression directly in live cells of any desired origin without the need for manipulation, thus allowing conservation of the genetic background of the target cell. Furthermore, it represents an easy, scalable method for efficient screening of pluripotency which is highly desirable during high-throughput cell reprogramming and after genomic editing of pluripotent stem cells., (© 2014 AlphaMed Press.)
- Published
- 2015
- Full Text
- View/download PDF
8. RNAseq Analysis of Isogenic Human Induced Pluripotent Stem Cell Lines Reveals Differential Gene Expression Patterns during Differentiation of Human Heart Organoids Due to a Patient-Specific TBX5 Mutation.
- Author
-
Lahm, H., Northoff, B.H., Reinsch, M., Mantani, A., Neb, I., Dzilic, E., Doppler, S., Lange, R., Holdt, L.M., Hansen, A., Krane, M., and Dreßen, M.
- Subjects
PLURIPOTENT stem cells ,GENE expression ,GENE ontology ,CELL lines ,RNA sequencing ,INDUCED pluripotent stem cells - Abstract
This article discusses the use of human induced pluripotent stem cells (iPSCs) to study the effects of a disease-causing TBX5 mutation on the development of human heart organoids (hHOs). The researchers compared isogenic iPSC lines with and without the TBX5 mutation and found that both lines were equally capable of generating hHOs. However, hHOs derived from iPSCs with the TBX5 mutation showed dysregulation in several essential pathways, including extracellular matrix organization and muscle structure development. This study demonstrates the potential of hHOs as a powerful tool for studying the effects of genetic mutations on early cardiac development. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
9. Identification of Differentially Regulated Pathways in Cardiac Development and Cardiac Gene Expression during In Vitro Cardiac Differentiation of HLHS-derived Human Induced Pluripotent Stem Cells using Transcriptome Analysis.
- Author
-
Hoelscher, S. C., Doppler, S., Stich, T., Kistner, A., Lahm, H., Dreßen, M., Lange, R., Hassel, D., and Krane, M.
- Subjects
HEART development ,GENE expression ,INDUCED pluripotent stem cells ,CELL differentiation ,GENETIC transcription - Published
- 2018
- Full Text
- View/download PDF
10. Sequential defects in cardiac lineage commitment and maturation cause hypoplastic left heart syndrome
- Author
-
Stefanie Sudhop, Harald Lahm, Thomas Brade, Sharon L. Paige, Alexander Goedel, Svenja Laue, Thomas Meitinger, Markus Krane, Stefanie A. Doppler, Alessandra Moretti, Connie R. Bezzina, Pedro Schneider, Zhong Zhang, Makoto Sahara, Neil E. Bowles, Hilansi Rawat, Riccardo Berutti, Nazan Puluca, Ilaria My, Peter J. Gruber, Andreas Dendorfer, Ralf Gilsbach, Nora Lang, M. Dreßen, Christine M. Schneider, S. Schwarz, Daniel Sinnecker, I. Neb, Gianluca Santamaria, Karl-Ludwig Laugwitz, Rüdiger Lange, Sean M. Wu, Bruce D. Gelb, C. Abou-Ajram, Tatjana Dorn, Fleur V.Y. Tjong, Lia Crotti, Maria Rijlaarsdam, Matthias Mann, Christian Kupatt, Lutz Hein, Julie Cleuziou, Elisa Mastantuono, Lesca M. Holdt, Sophia Doll, Bernd H. Northoff, Cardiology, ACS - Heart failure & arrhythmias, Krane, M, Dressen, M, Santamaria, G, My, I, Schneider, C, Dorn, T, Laue, S, Mastantuono, E, Berutti, R, Rawat, H, Gilsbach, R, Schneider, P, Lahm, H, Schwarz, S, Doppler, S, Paige, S, Puluca, N, Doll, S, Neb, I, Brade, T, Zhang, Z, Abou-Ajram, C, Northoff, B, Holdt, L, Sudhop, S, Sahara, M, Goedel, A, Dendorfer, A, Tjong, F, Rijlaarsdam, M, Cleuziou, J, Lang, N, Kupatt, C, Bezzina, C, Lange, R, Bowles, N, Mann, M, Gelb, B, Crotti, L, Hein, L, Meitinger, T, Wu, S, Sinnecker, D, Gruber, P, Laugwitz, K, and Moretti, A
- Subjects
Organogenesis ,whole exome sequencing ,Hypoplastic left heart syndrome ,Pathogenesis ,Transcriptome ,0302 clinical medicine ,Original Research Articles ,Induced pluripotent stem cell ,Exome sequencing ,0303 health sciences ,Heart development ,Myogenesis ,hypoplastic left heart syndrome ,unfolded protein response ,Cell cycle ,heart defects, congenital ,Hypoplasia ,ddc ,3. Good health ,Autophagy ,Cell Cycle ,Heart Defects, Congenital ,Hypoplastic Left Heart Syndrome ,Induced Pluripotent Stem Cells ,Unfolded Protein Response ,Whole Exome Sequencing ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Cardiology ,Heart defects ,cell cycle ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,autophagy ,medicine.medical_specialty ,induced pluripotent stem cells ,Ventricular outflow tract obstruction ,Biology ,Genetic Heterogeneity ,03 medical and health sciences ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,030304 developmental biology ,Lineage commitment ,business.industry ,Genetic heterogeneity ,congenital ,Human heart ,medicine.disease ,Unfolded protein response ,Cancer research ,business ,030217 neurology & neurosurgery - Abstract
Supplemental Digital Content is available in the text., Background: Complex molecular programs in specific cell lineages govern human heart development. Hypoplastic left heart syndrome (HLHS) is the most common and severe manifestation within the spectrum of left ventricular outflow tract obstruction defects occurring in association with ventricular hypoplasia. The pathogenesis of HLHS is unknown, but hemodynamic disturbances are assumed to play a prominent role. Methods: To identify perturbations in gene programs controlling ventricular muscle lineage development in HLHS, we performed whole-exome sequencing of 87 HLHS parent–offspring trios, nuclear transcriptomics of cardiomyocytes from ventricles of 4 patients with HLHS and 15 controls at different stages of heart development, single cell RNA sequencing, and 3D modeling in induced pluripotent stem cells from 3 patients with HLHS and 3 controls. Results: Gene set enrichment and protein network analyses of damaging de novo mutations and dysregulated genes from ventricles of patients with HLHS suggested alterations in specific gene programs and cellular processes critical during fetal ventricular cardiogenesis, including cell cycle and cardiomyocyte maturation. Single-cell and 3D modeling with induced pluripotent stem cells demonstrated intrinsic defects in the cell cycle/unfolded protein response/autophagy hub resulting in disrupted differentiation of early cardiac progenitor lineages leading to defective cardiomyocyte subtype differentiation/maturation in HLHS. Premature cell cycle exit of ventricular cardiomyocytes from patients with HLHS prevented normal tissue responses to developmental signals for growth, leading to multinucleation/polyploidy, accumulation of DNA damage, and exacerbated apoptosis, all potential drivers of left ventricular hypoplasia in absence of hemodynamic cues. Conclusions: Our results highlight that despite genetic heterogeneity in HLHS, many mutations converge on sequential cellular processes primarily driving cardiac myogenesis, suggesting novel therapeutic approaches.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.